UPDATED Apr 23, 2024
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
WTC | AU$91.59 | 3.0% | 33.1% | AU$30.3b | AU$88.99 | PE136.9x | E27.2% | 0.2% | Software | ||
GMG | AU$31.36 | 0.2% | 61.4% | AU$58.6b | AU$29.88 | PB3.4x | E26.2% | 1.0% | Real Estate | ||
REA | AU$180.22 | 2.2% | 28.6% | AU$24.0b | AU$174.31 | PE84.5x | E20.5% | 0.9% | Media | ||
XRO | AU$119.81 | 0.9% | 28.0% | AU$18.5b | AU$130.36 | PS13x | E42.4% | n/a | Software | ||
WOW | AU$32.07 | 0.8% | -18.2% | AU$39.0b | AU$35.46 | PB7.7x | E46.9% | 3.3% | Consumer Retailing | ||
JHX | AU$54.72 | 1.3% | 64.2% | AU$23.8b | AU$58.70 | PE28.9x | E14.0% | n/a | Materials | ||
BHP | AU$45.23 | 1.8% | 2.8% | AU$230.7b | AU$47.40 | PE20.2x | E14.0% | 4.8% | Materials | ||
CSL | AU$278.45 | 2.1% | -8.9% | AU$134.8b | AU$305.91 | PE35.5x | E14.7% | 1.3% | Pharmaceuticals & Biotech | ||
TCL | AU$12.90 | -0.3% | -15.1% | AU$39.9b | AU$13.30 | PE175.7x | E26.9% | 4.9% | Transportation | ||
SCG | AU$3.16 | 1.9% | 10.9% | AU$16.7b | AU$3.30 | PB0.9x | E20.4% | 5.3% | Real Estate | ||
ALL | AU$41.07 | 3.5% | 9.2% | AU$26.2b | AU$47.49 | PE17.9x | E5.1% | 1.7% | Consumer Services | ||
COH | AU$319.99 | 0.5% | 27.5% | AU$21.1b | AU$280.94 | PE59.8x | E12.2% | 1.3% | Healthcare |